Nishimura Rick A, Grantham J Aaron, Connolly Heidi M, Schaff Hartzell V, Higano Stuart T, Holmes David R
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA.
Circulation. 2002 Aug 13;106(7):809-13. doi: 10.1161/01.cir.0000025611.21140.34.
Although aortic valve replacement can be performed at an acceptable risk level in selected patients with left ventricular systolic dysfunction and low-output, low-gradient aortic stenosis, not all patients presenting with these hemodynamics will benefit from the operation. Some patients may have only mild aortic stenosis, despite a small calculated valve area. We report on the clinical utility of diagnostic dobutamine stimulation during cardiac catheterization in these diagnostically challenging patients.
Thirty-two patients with low-output, low-gradient aortic stenosis and an ejection fraction <40% had dobutamine infusion in the catheterization laboratory. On the basis of the results of the dobutamine test, 21 patients underwent aortic valve replacement. All patients with a final aortic valve area < or =1.2 cm2 at peak dobutamine infusion and a mean gradient of >30 mm Hg were found to have severe calcific aortic stenosis at operation. In the 15 patients in whom contractile reserve was identified during dobutamine challenge (increase in stroke volume >20%), 1 patient died perioperatively (7% mortality) and 12 patients were alive in New York Heart Association class I or II status at follow-up.
In patients with left ventricular systolic dysfunction and aortic stenosis with a low output and a low mean gradient, dobutamine challenge may aid in selecting those who would benefit from an aortic valve operation.
尽管对于部分左心室收缩功能障碍、低心输出量、低跨瓣压差的主动脉瓣狭窄患者,主动脉瓣置换术可在可接受的风险水平下进行,但并非所有具有这些血流动力学特征的患者都能从手术中获益。一些患者尽管计算得出的瓣口面积较小,但可能仅存在轻度主动脉瓣狭窄。我们报告了在心脏导管检查期间进行诊断性多巴酚丁胺激发试验对这些诊断困难的患者的临床应用价值。
32例低心输出量、低跨瓣压差且射血分数<40%的主动脉瓣狭窄患者在导管室接受了多巴酚丁胺输注。根据多巴酚丁胺试验结果,21例患者接受了主动脉瓣置换术。所有在多巴酚丁胺输注峰值时最终主动脉瓣口面积≤1.2 cm²且平均跨瓣压差>30 mmHg的患者在手术中均被发现存在严重钙化性主动脉瓣狭窄。在多巴酚丁胺激发试验期间发现有收缩储备(每搏量增加>20%)的15例患者中,1例围手术期死亡(死亡率7%),12例患者在随访时纽约心脏协会心功能分级为Ⅰ或Ⅱ级且存活。
对于左心室收缩功能障碍且伴有低心输出量和低平均跨瓣压差的主动脉瓣狭窄患者,多巴酚丁胺激发试验可能有助于筛选出能从主动脉瓣手术中获益的患者。